IO Biotech, Inc. (IOBTQ) Cash from Investing Activities (2021 - 2025)

IO Biotech (IOBTQ) has 5 years of Cash from Investing Activities data on file, last reported at -$4000.0 in Q3 2025.

• Quarterly Cash from Investing Activities rose 60.0% year-over-year to -$4000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$69000.0 (up 52.41% YoY) and the FY2024 annual result came in at -$44000.0, up 86.38% from the prior year.
• Cash from Investing Activities improved to -$4000.0 in Q3 2025, from -$26000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$4000.0 in Q3 2025 to a low of -$349000.0 in Q4 2022.
• A 5-year average of -$79062.5 and a median of -$33500.0 in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 92.57% — and 2025, when it slumped 154.55%.
• Tracing IOBTQ's Cash from Investing Activities over 5 years: stood at -$150000.0 in 2021, then plunged by 132.67% to -$349000.0 in 2022, then soared by 67.91% to -$112000.0 in 2023, then soared by 90.18% to -$11000.0 in 2024, then jumped by 63.64% to -$4000.0 in 2025.
• The last three Cash from Investing Activities figures came in at -$4000.0 (Q3 2025), -$26000.0 (Q2 2025), and -$28000.0 (Q1 2025), per Business Quant data.